EUVIMEDEUVIMED entdecken
Crossref

Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series

Iris Dirven iD, Manon Vounckx, Jolien I Kessels, Justine Lauwyck, Gil Awada, Anne-Marie Vanbinst, Bart Neyns

Pigment Cell & Melanoma Research · 2024

DOI: 10.1111/pcmr.13186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Iris Dirven und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel)/Vrije Universiteit Brussel (VUB), Brussels, Belgium. Hauptthemen laut MEDLINE: Melanoma, Biomarkers, Tumor, Meningeal Neoplasms, Circulating Tumor DNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptomeningeal melanoma metastases (LMM) are associated with poor survival. Diagnosis is based on clinical presentation, brain MRI and cerebrospinal fluid (CSF) analysis. Inconclusive findings at initial presentation can delay treatment. In this single‐center case series, detection of BRAF V600 ‐ and NRAS Q61 ‐mutant cell‐free tumor DNA (cfDNA) in CSF was evaluated as a complementary diagnostic biomarker. In 12 patients with clinical suspicion of LMM, a retrospective analysis of MRI, CSF cytology and cfDNA analysis on 1 mL of CSF using the Idylla® platform was carried out. Nine patients displayed MRI abnormalities suggesting LMM. CSF analysis identified malignant cells in three patients (including one without MRI abnormalities). BRAF V600 ‐ or NRAS Q61 ‐mutant cfDNA was detected in CSF of nine patients (eight with and one without MRI abnormalities; all patients with positive CSF cytology). Subsequent follow‐up confirmed LMM in all patients with positive and in one patient with a negative CSF cfDNA analysis (sensitivity 81.8%; specificity 100%). Our findings suggest that analyzing BRAF V600 ‐ and NRAS Q61 ‐mutant cfDNA in CSF using the Idylla® platform holds promise as a sensitive and specific complementary diagnostic biomarker for LMM, particularly in case of inconsistency between imaging and CSF cytology. The 110‐min analysis can facilitate urgent treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaBiomarkers, TumorMeningeal NeoplasmsCirculating Tumor DNAHumansMaleFemaleMiddle AgedAgedAdultProto-Oncogene Proteins B-rafRetrospective StudiesMutationGTP PhosphohydrolasesCell-Free Nucleic AcidsMembrane ProteinsAged, 80 and over

Stichwörter der Autor:innen

biomarkerbrain metastasescell‐free tumor DNAcerebrospinal fluidleptomeningeal metastasis

Substanzen

Biomarkers, TumorCirculating Tumor DNAProto-Oncogene Proteins B-rafNRAS protein, humanBRAF protein, humanGTP PhosphohydrolasesCell-Free Nucleic AcidsMembrane Proteins

Autor:innen und Institutionen

  • Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel)/Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Department of Medical Oncology, Algemeen Ziekenhuis Sint-Lucas, Brugge, Belgium.
  • Department of Radiology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

ORCID-Profile: Iris Dirven

Zitieren

APA

Dirven, I., Vounckx, M., Kessels, J. I., Lauwyck, J., Awada, G., Vanbinst, A. M., & Neyns, B. (2024). Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13186

Vancouver

Dirven I, Vounckx M, Kessels JI, Lauwyck J, Awada G, Vanbinst AM, et al. Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13186

BibTeX
@article{Dirven2024,
  author = {Dirven, Iris and Vounckx, Manon and Kessels, Jolien I and Lauwyck, Justine and Awada, Gil and Vanbinst, Anne-Marie and Neyns, Bart},
  title = {Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series},
  journal = {Pigment Cell & Melanoma Research},
  year = {2024},
  doi = {10.1111/pcmr.13186}
}
Kostenlos starten →